Benchmark's much touted new sea lice treatment cleared for commercialization in Norway

The company has now completed all the regulatory steps required to sell the product in the world's most important salmon farming market.

The company already received marketing authorization from the Norwegian Medicines Agency (NoMA) in early July.
The company already received marketing authorization from the Norwegian Medicines Agency (NoMA) in early July.Foto: GLENN ROKEBERG
Published 15 July 2021, 19:45Updated 15 July 2021, 19:45